Clinical trial

Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in…

NCT00190567 · Eli Lilly and Company, Industry · Completed

Key facts

NCT number NCT00190567
Title Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence
Official title Biomechanical Effects of Duloxetine on Bladder Function and Sphincter Resistance During the Emptying Phase and on Urethral Function During the Filling Phase of the Micturition Cycle in Women With Pure Genuine Stress Incontinence
Lead sponsor Eli Lilly and Company, Industry
Collaborators Boehringer Ingelheim Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Urinary Stress Incontinence
Intervention type Drug
Interventions duloxetine, Placebo
Enrollment 50
Start date Oct 1, 2001
Completion Apr 1, 2006
First posted Sep 19, 2005
Last update posted Jan 26, 2007
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies